Healthcare provider profile · identity verified

Brian Hilgeman, M.D.

Internal Medicine · MILWAUKEE, WI · NPI 1104141126

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	508	109
Amlodipine Besylate	Amlodipine Besylate	305	64
Gabapentin	Gabapentin	282	56
Albuterol Sulfate Hfa	Albuterol Sulfate	194	37
Lisinopril	Lisinopril	171	44
Omeprazole	Omeprazole	168	45
Rosuvastatin Calcium	Rosuvastatin Calcium	168	42
Metformin Hcl	Metformin Hcl	155	39
Duloxetine Hcl	Duloxetine Hcl	152	26
Losartan Potassium	Losartan Potassium	138	39
Pantoprazole Sodium	Pantoprazole Sodium	135	27
Carvedilol	Carvedilol	134	26
Metformin Hcl Er	Metformin Hcl	134	29
Metoprolol Succinate	Metoprolol Succinate	128	23
Tizanidine Hcl	Tizanidine Hcl	122	30
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	121	14
Levothyroxine Sodium	Levothyroxine Sodium	112	28
Jardiance	Empagliflozin	109	27
Fluticasone Propionate	Fluticasone Propionate	106	34
Trazodone Hcl	Trazodone Hcl	106	17
Mirtazapine	Mirtazapine	105	23
Escitalopram Oxalate	Escitalopram Oxalate	104	24
Sertraline Hcl	Sertraline Hcl	102	26
Furosemide	Furosemide	94	22
Bupropion Xl	Bupropion Hcl	85	16
Montelukast Sodium	Montelukast Sodium	84	12
Pregabalin	Pregabalin	81	22
Bumetanide	Bumetanide	80	18
Trulicity	Dulaglutide	77	20
Clopidogrel	Clopidogrel Bisulfate	75	14
Tramadol Hcl	Tramadol Hcl	74	16
Eliquis	Apixaban	72	18
Oxycodone Hcl	Oxycodone Hcl	67	15
Potassium Chloride	Potassium Chloride	67	14
Diclofenac Sodium	Diclofenac Sodium	65	23
Allopurinol	Allopurinol	61	14
Spironolactone	Spironolactone	61	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	57	21
Acetaminophen-Codeine	Acetaminophen With Codeine	55	13
Tamsulosin Hcl	Tamsulosin Hcl	55	18
Lidocaine	Lidocaine	54	12
Pravastatin Sodium	Pravastatin Sodium	50	17
Ozempic	Semaglutide	49	15
Ondansetron Odt	Ondansetron	47	14
Oxybutynin Chloride Er	Oxybutynin Chloride	47	suppressed
Hydralazine Hcl	Hydralazine Hcl	43	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	43	suppressed
Hydrocortisone	Hydrocortisone	43	suppressed
Levetiracetam	Levetiracetam	43	suppressed
Breo Ellipta	Fluticasone/Vilanterol	41	suppressed
Donepezil Hcl	Donepezil Hcl	41	suppressed
Famotidine	Famotidine	41	15
Entresto	Sacubitril/Valsartan	40	suppressed
Alendronate Sodium	Alendronate Sodium	38	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	38	13
Nystatin	Nystatin	38	12
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	37	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	37	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	36	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	35	suppressed
Prednisone	Prednisone	35	22
Celecoxib	Celecoxib	34	suppressed
Baclofen	Baclofen	33	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	32	suppressed
Nystop	Nystatin	30	suppressed
Simvastatin	Simvastatin	30	11
Ibuprofen	Ibuprofen	29	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	26	12
Triamcinolone Acetonide	Triamcinolone Acetonide	26	12
Varenicline Tartrate	Varenicline Tartrate	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Finasteride	Finasteride	25	suppressed
Loperamide	Loperamide Hcl	25	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	25	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	23	suppressed
Ketoconazole	Ketoconazole	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Valsartan	Valsartan	21	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Topiramate	Topiramate	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Humulin R U-500 Kwikpen	Insulin Regular, Human	17	suppressed
Linzess	Linaclotide	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Ciclopirox	Ciclopirox	16	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	16	suppressed
Meloxicam	Meloxicam	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Zenpep	Lipase/Protease/Amylase	16	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	15	suppressed
Clonazepam	Clonazepam	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Naproxen	Naproxen	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	14	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	14	suppressed
Tivicay	Dolutegravir Sodium	14	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Brilinta	Ticagrelor	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Jentadueto	Linagliptin/Metformin Hcl	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Oxcarbazepine	Oxcarbazepine	13	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Metolazone	Metolazone	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Triumeq	Abacavir/Dolutegravir/Lamivudi	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error